Business Description
Abiomed Inc
NAICS : 339112
SIC : 3841
ISIN : US0036541003
Share Class Description:
ABMD: Ordinary SharesDescription
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 68.64 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.5 | |||||
| 3-Year EBITDA Growth Rate | 6.2 | |||||
| 3-Year EPS without NRI Growth Rate | -19 | |||||
| 3-Year FCF Growth Rate | 6.4 | |||||
| 3-Year Book Growth Rate | 16.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 51.95 | |||||
| 12-1 Month Momentum % | 7.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.93 | |||||
| Quick Ratio | 7.17 | |||||
| Cash Ratio | 6.12 | |||||
| Days Inventory | 170.24 | |||||
| Days Sales Outstanding | 30.9 | |||||
| Days Payable | 60.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 4.04 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.32 | |||||
| Operating Margin % | 23.66 | |||||
| Net Margin % | 24.84 | |||||
| FCF Margin % | 20.22 | |||||
| ROE % | 18.03 | |||||
| ROA % | 16.27 | |||||
| ROIC % | 23.88 | |||||
| ROC (Joel Greenblatt) % | 85.34 | |||||
| ROCE % | 16.85 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 65.47 | |||||
| PE Ratio without NRI | 65.47 | |||||
| Shiller PE Ratio | 115.28 | |||||
| Price-to-Owner-Earnings | 79.51 | |||||
| PEG Ratio | 3.12 | |||||
| PS Ratio | 16.28 | |||||
| PB Ratio | 11.18 | |||||
| Price-to-Tangible-Book | 12.15 | |||||
| Price-to-Free-Cash-Flow | 80.57 | |||||
| Price-to-Operating-Cash-Flow | 69.72 | |||||
| EV-to-EBIT | 64.38 | |||||
| EV-to-EBITDA | 58.08 | |||||
| EV-to-Revenue | 15.23 | |||||
| EV-to-FCF | 75.32 | |||||
| Price-to-Projected-FCF | 4.27 | |||||
| Price-to-DCF (Earnings Based) | 1.9 | |||||
| Price-to-DCF (FCF Based) | 2.34 | |||||
| Price-to-Median-PS-Value | 1.19 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.83 | |||||
| Price-to-Graham-Number | 5.95 | |||||
| Price-to-Net-Current-Asset-Value | 18.99 | |||||
| Price-to-Net-Cash | 25.94 | |||||
| Earnings Yield (Greenblatt) % | 1.55 | |||||
| FCF Yield % | 1.24 | |||||
| Forward Rate of Return (Yacktman) % | 14.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ABMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abiomed Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,074.096 | ||
| EPS (TTM) ($) | 5.82 | ||
| Beta | 0 | ||
| Volatility % | 63.99 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.9525 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 7.26 | ||
| 52-Week Range ($) | 219.845 - 381.99 | ||
| Shares Outstanding (Mil) | 45.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abiomed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abiomed Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Abiomed Inc Frequently Asked Questions
What is Abiomed Inc(ABMD)'s stock price today?
The current price of ABMD is $381.02. The 52 week high of ABMD is $381.99 and 52 week low is $219.85.
When is next earnings date of Abiomed Inc(ABMD)?
The next earnings date of Abiomed Inc(ABMD) is 2024-04-28 Est..
Does Abiomed Inc(ABMD) pay dividends? If so, how much?
Abiomed Inc(ABMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers